These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23827761)

  • 1. Influence of cellulose derivative and ethylene glycol on optimization of lornoxicam transdermal formulation.
    Shahzad Y; Khan Q; Hussain T; Shah SN
    Int J Biol Macromol; 2013 Oct; 61():26-32. PubMed ID: 23827761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying response surface methodology to optimize nimesulide permeation from topical formulation.
    Shahzad Y; Afreen U; Nisar Hussain Shah S; Hussain T
    Pharm Dev Technol; 2013; 18(6):1391-8. PubMed ID: 22994526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-articular drug delivery from an optimized topical patch containing teriflunomide and lornoxicam for rheumatoid arthritis treatment: does the topical patch really enhance a local treatment?
    Xi H; Cun D; Xiang R; Guan Y; Zhang Y; Li Y; Fang L
    J Control Release; 2013 Jul; 169(1-2):73-81. PubMed ID: 23567043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro & in vivo studies on lornoxicam loaded nanoemulsion gels for topical application.
    Dasgupta S; Ghosh SK; Ray S; Kaurav SS; Mazumder B
    Curr Drug Deliv; 2014; 11(1):132-8. PubMed ID: 24266509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation Optimization and In-vitro and In-vivo Evaluation of Lornoxicam Ethosomal Gels with Penetration Enhancers.
    Li K; Gao S; Tian B; Shi Y; Lv Q; Han J
    Curr Drug Deliv; 2018; 15(3):424-435. PubMed ID: 29219057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.
    Shah H; Nair AB; Shah J; Bharadia P; Al-Dhubiab BE
    Daru; 2019 Jun; 27(1):59-70. PubMed ID: 30701460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation study of topically applied lotion: in vitro and in vivo evaluation.
    Hussain Shah SN; Hussain T; Ullah Khan I; Asghar S; Shahzad Y
    Bioimpacts; 2013; 3(1):11-9. PubMed ID: 23678465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between hydrogen-bonded ion-pair stability and transdermal penetration of lornoxicam with organic amines.
    Xi H; Wang Z; Chen Y; Li W; Sun L; Fang L
    Eur J Pharm Sci; 2012 Sep; 47(2):325-30. PubMed ID: 22579706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution enhancement and formulation of rapid-release lornoxicam mini-tablets.
    Tawfeek HM; Saleem IY; Roberts M
    J Pharm Sci; 2014 Aug; 103(8):2470-83. PubMed ID: 24995853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of skin permeation and analgesic activity effects of carbopol lornoxicam topical gels containing penetration enhancer.
    Al-Suwayeh SA; Taha EI; Al-Qahtani FM; Ahmed MO; Badran MM
    ScientificWorldJournal; 2014; 2014():127495. PubMed ID: 25045724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and evaluation of proniosomes containing lornoxicam.
    Madan JR; Ghuge NP; Dua K
    Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels.
    Attia MA; El-Gibaly I; Shaltout SE; Fetih GN
    Int J Pharm; 2004 May; 276(1-2):11-28. PubMed ID: 15113610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A QUALITY BY DESIGN APPROACH: FABRICATION, CHARACTERIZATION AND EVALUATION OF OPTIMIZED TRANSDERMAL THERAPEUTIC SYSTEM FOR ANTIRHEUMATIC LORNOXICAM.
    Naeem M; Pervaiz F; Nawaz Z; Yousup M; Ali A; Khalid N; Khan JA
    Acta Pol Pharm; 2017 Jan; 74(1):249-266. PubMed ID: 29474780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, and physical, in vitro and ex vivo evaluation of transdermal ibuprofen hydrogels containing turpentine oil as penetration enhancer.
    Khan NR; Khan GM; Wahab A; Khan AR; Hussain A; Nawaz A; Akhlaq M
    Pharmazie; 2011 Nov; 66(11):849-52. PubMed ID: 22204130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation.
    Bachhav YG; Patravale VB
    Acta Pharm; 2010 Jun; 60(2):153-63. PubMed ID: 21134852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate optimization of formulation variables influencing flurbiprofen proniosomes characteristics.
    Zidan AS; Mokhtar M
    J Pharm Sci; 2011 Jun; 100(6):2212-21. PubMed ID: 21259237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain.
    Abdelbary GA; Aburahma MH
    J Liposome Res; 2015; 25(2):107-21. PubMed ID: 25058447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity.
    Kumbhar D; Wavikar P; Vavia P
    AAPS PharmSciTech; 2013 Sep; 14(3):1072-82. PubMed ID: 23818079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of mini-tablets-filled-pulsincap delivery of lornoxicam in the chronotherapeutic treatment of rheumatoid arthritis.
    Hadi MA; Rao NG; Rao AS
    Pak J Pharm Sci; 2015 Jan; 28(1):185-93. PubMed ID: 25553695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.